We serve Chemical Name:Metatartaric acid CAS:39469-81-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Metatartaric acid
CAS.NO:39469-81-3
Synonyms:Metatartaric acid
Molecular Formula:C8H8O10
Molecular Weight:264.14300
HS Code:2918120000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:167.66000
Exact Mass:264.01200
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Metatartaric acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Metatartaric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Metatartaric acid Use and application,Metatartaric acid technical grade,usp/ep/jp grade.
Related News: In that group, the vaccine slowed brain decline by around 30% in two different clinical and functional tests, Novak said. Metatartaric acid manufacturer ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� Metatartaric acid supplier Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. Metatartaric acid vendor DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. Metatartaric acid factory Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion.
